I don’t have an exact, public “timeline” for Apotex’s ruxolitinib filing. If the company submitted a generic ruxolitinib ANDA, or if there was related regulatory or patent litigation, the precise dates are not published in a single place. Instead, you’d have to assemble them from multiple public records (regulatory databases, court dockets, and patent status pages), and typically some steps (like whether an ANDA was approved) may not be publicly disclosed.
If you want a precise timeline, tell me the jurisdiction and date range you care about (for example: U.S. FDA, Canada Health Canada, EU/ECHA, etc.). I can guide you on how to pull the dates from public sources and assemble them into a timeline. Here’s how you can build it yourself in the meantime:
Where to look (public sources)
- United States (FDA)
- Drugs@FDA: search for ruxolitinib and filter by applicant (Apotex) to see any approvals or submissions.
- FDA Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations): look for Apotex’s ANDA entries for ruxolitinib, including filing dates, approval dates (if any), and status.
- Patent and Exclusivity data within FDA resources: to see if there was a Paragraph IV certification and any associated exclusivity.
- Court dockets (PACER or other court databases): to track patent litigation (e.g., Incyte vs. Apotex) and any 30-month stay related to ANDA actions.
- Canada (Health Canada)
- Health Canada Drug Product Database: check for any Apotex submissions or approvals related to ruxolitinib.
- Any Health Canada decision letters or guidance that mention generic ruxolitinib.
- European Union
- EMA/EudraNet records and any press releases or procedural documents mentioning Apotex and ruxolitinib.
- Patents and exclusivity
- Look up Incyte’s patent status and expiry dates for ruxolitinib in the relevant jurisdictions to understand likely timing for generic challenges.
How I can help if you want me to fetch and assemble
- Tell me:
- Jurisdiction(s) of interest (e.g., US, Canada, EU).
- Time window (start year to end year).
- Whether you want only regulatory submission/approval dates or also patent litigation milestones.
- I’ll outline a structured timeline using publicly available data and note any gaps where data isn’t publicly disclosed.
If you’d like, I can also guide you through a request to the appropriate regulator or provide a template for compiling the timeline (with sections for submission date, acceptance, patent status, litigation events, approval status, and launch date).